New Enterprise Associates related stories
All articles and analysis
Mirum Pharmaceuticals nabs $120 mln Series A in NEA-led roundMirum Pharmaceuticals, a clinical-stage therapeutics company focused on treating cholestatic liver diseases, has secured $120 million in Series A financing. New Enterprise Associates led the round with participation from Deerfield Management, Frazier Healthcare Partners, Novo Holdings A/S, Pappas Capital, RiverVest Venture Partners and Rock Springs Capital.
- NEA promotes Schottenstein to principal
New Enterprise Associates Inc has promoted Julia Schottenstein to principal. Prior to joining the firm, Schottenstein was an investment banker at Qatalyst Partners.
- ScienceLogic raises $25 mln growth funding from Square 1 Bank
Reston, Virginia-based ScienceLogic, a provider of artificial intelligence software for IT operations management, announced that it has secured $25 million in growth financing from Square 1 Bank, a division of Pacific Western Bank. The company, founded in 2003, previously raised more than $80 million in funding from Goldman Sachs, Intel Capital and New Enterprise Associates.
- WireWheel grabs $10 mln Series A
Arlington, Virginia-based WireWheel, a software-as-a-service platform "that modernizes global data privacy compliance," has raised $10 million in Series A funding. New Enterprise Associates and PSP Growth led the round.
- Infoworks attracts $25 mln Series C
Palo Alto, California-based Infoworks, a software platform provider for agile data engineering, has raised $25 million in Series C funding. New Enterprise Associates led the round with participation from return backers Nexus Venture Partners and Centerview Capital Technology.
- Qpex Biopharma nabs $33 mln Series A
Qpex Biopharma, a developer of antiobiotics, has raised $33 million in Series A financing. New Enterprise Associates led the round with participation from Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Draper Fund.